Estimation of urinary cotinine cut-off points distinguishing non-smokers, passive and active smokers

References

• Agewall S, Persson B, Lindstedt G, Fagerberg B. Smoking and use of smokeless tobacco in treated hypertensive men at high coronary risk: utility of urinary cotinine determination. British Journal of Biomedical Science 2002; 59: 145–149
   PubMed Web of Science ®Google Scholar
• Apseloff G, Ashton HM, Friedman H, Gerber N. The importance of measuring cotinine levels to identify smokers in clinical trials. Clinical Pharmacology and Therapeutics 1994; 56: 460–462
   PubMed Web of Science ®Google Scholar
• Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke. Nearly as large as smoking, Circulation 2005; 111: 2684–2698
   PubMed Web of Science ®Google Scholar
• Becker K, Schulz C, Kaus S, Seiwert M, Seifert B. German Environmental Survey 1998 (Ger ES III): environmental pollutants in the urine of German population. International Journal of Hygiene and Environmental Health 2003; 206: 15–24
   PubMed Web of Science ®Google Scholar
• Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiological Reviews 1996; 18: 188–204
   PubMed Web of Science ®Google Scholar
• Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Anderson A. Serum cotinine levels as predictor of lung cancer risk. Cancer Epidemiology Biomarkers and Prevention 2006; 15: 1184–1188
   Web of Science ®Google Scholar
• Bramer SL, Kallungal BA. Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers 2003; 8: 187–203
   PubMed Web of Science ®Google Scholar
• Chambers KL, Ellard GA, Hewson AT, Smith RF. Urine test the assessment of smoking status. British Journal of Biomedical Science 2001; 58: 61–65
   Google Scholar
• Cok I, Öztürk R. Urinary cotinine levels of smokeless tobacco (Maras powder) users. Human and Experimental Toxicology 2000; 19: 650–655
   PubMed Web of Science ®Google Scholar
• Cummings KM, Markello SJ, Mahoney M, Bhargava AK, McElroy PD, Marshall JR. Measurement of current exposure to environmental tobacco smoke. Archives of Environmental Health 1990; 45: 74–79
   PubMed Web of Science ®Google Scholar
• Gilbert DD. Chemical analyses as validators in smoking cessation programs. Journal of Behavioral Medicine 1993; 16: 295–308
   PubMedGoogle Scholar
• Greaves R, Trotter L, Brennecke S, Janus E. A simple high-pressure liquid chromatography cotinine assay: validation of smoking status in pregnant women. Annals of Clinical Biochemistry 2001; 38: 333–338
   PubMedGoogle Scholar
• Hammond D, Fong GT, Cummings KM, Hyland A. Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiology Biomarkers and Prevention 2005; 14: 1370–1375
   PubMed Web of Science ®Google Scholar
• Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: a mini review. International Archives of Occupational and Environmental Health 1998; 71: 162–168
   PubMed Web of Science ®Google Scholar
• Henderson FW, Reid HF, Morris R, Wang OL, Hu PC, Helms RW, Forehand L, Mumford J, Lewtas J, Haley NJ. Home air nicotine levels and urinary cotinine excretion in preschool children. American Review of Respiratory Disease 1989; 140: 197–201
   PubMedGoogle Scholar
• Hobbs SD, Wilmik ABM, Adam DJ, Bradbury AW. Assessment of smoking status in patients with peripheral arterial disease. Journal of Vascular Surgery 2005; 41: 451–456
   Google Scholar
• Holl RW, Grabert M, Heinze E, Debatin KM. Objective assessment of smoking habits by urinary cotinine measurement in adolescents and young adults with type 1 diabetes. Diabetes Care 1998; 21: 787–791
   Google Scholar
• Jarvis MJ, Russell MAH, Benowitz NL, Feyerabend C. Elimination of cotinine from body fluids: implications for non-invasive measurement of tobacco smoke exposure. American Journal of Public Health 1988; 78: 696–698
   PubMed Web of Science ®Google Scholar
• Lee PN. Marriage to a smoker’ may not be a valid marker of exposure in studies relating environmental tobacco smoke to risk of lung cancer in Japanese non-smoking women. International Archives of Occupational and Environmental Health 1995; 67: 287–294
   PubMed Web of Science ®Google Scholar
• Malaiyandi V, Sellers EM, Tyndale RF. Implications of CYP 2A6 genetic variation for smoking behaviors and nicotine dependence. Clinical Pharmacology and Therapeutics 2005; 77: 145–158
   PubMed Web of Science ®Google Scholar
• Malaiyandi V, Goodz SD, Sellers EM, Tyndale RF. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. Cancer Epidemiology Biomarkers and Prevention 2006; 15: 1812–1819
   Google Scholar
• Nakajima M, Yamamoto T, Kuroiwa Y, Yokoi T. Improved highly sensitive method for determination of nicotine and cotinine in human plasma by high-performance liquid chromatography. Journal of Chromatography B, Biomedical Sciences and Applications 2000; 742: 211–215
   PubMed Web of Science ®Google Scholar
• Patterson F, Benowitz N, Shields P, Kaufmann V, Jepson C, Wileyto P, Kucharski S, Lerman C. Individual differences in nicotine intake per cigarette. Cancer Epidemiology, Biomarkers and Prevention 2003; 12: 468–471
   PubMed Web of Science ®Google Scholar
• Pichini S, Altieri I, Pacifici R, Rosa M, Ottaviani G, Zuccaro P. Simultaneous determination of cotinine and trans-3’-hydroxycotinine in human serum by high-performance liquid chromatography. Journal of Chromatography 1992; 577: 358–361
   Google Scholar
• Piekoszewski, W, Florek, E, Wrzosek, J. 2002. Using urinary cotinine tests to check the validity of tobacco smoking and ETS exposure survey responses. 3rd European Conference on Tobacco or Health Closing the Gaps – Solidarity for Health. June 20–22, 2002, Warsaw, Poland. Abstract III A4.
   Google Scholar
• Savitz DA, Dole N, Terry JW, Jr, Zhou H, Throp JM, Jr. Smoking and pregnancy outcome among African-American and white women in Central North Carolina. Epidemiology 2001; 12: 636–642
   PubMed Web of Science ®Google Scholar
• Scherer G. Biomonitoring of inhaled complex mixtures – ambient air, diesel exhaust and cigarette smoke. Experimental and Toxicologic Pathology 2005; 57: 75–110
   PubMed Web of Science ®Google Scholar
• Secker-Walker RH, Vacek PM, Flynn BS, Mead PB. Exhaled carbon monoxide and urinary cotinine as measures of smoking in pregnancy. Addictive Behaviors 1997; 22: 671–684
   Google Scholar
• Society for Research on Nicotine and Tobacco SRNT Subcommittee on Biochemical Verification. 2002. Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research, 4:149–159.
   Google Scholar
• Suter, PM, Spitzbarth, A, Gautschi, K, Erdmenger, L, Vonderschmitt, DJ, Vetter, W. 1995Cotinine – a useful biomarker for tobacco consumption? in German) Schweizerische Rundschau für Medizine (Praxis). 84: 821–825.
   Google Scholar
• Taylor, JR. 1999. An Introduction to Error Analysis. (in Polish). Warsaw: Scientific Publisher PWN. p. 149–181.
   Google Scholar
• US Department of Health and Human Services. 2006. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of Surgeon General. Atlanta, GA ( available at, , http://www.surgeongeneral.gov/library).
   Google Scholar
• Vine MF, Hulka BS, Margolin BH, Truong YK, Hu P, Schramm MM, Griffith JD, McCann M, Everson RB. Cotinine concentrations in semen, urine and blood of smokers and nonsmokers. American Journal of Public Health 1993; 83: 1335–1338
   PubMed Web of Science ®Google Scholar
• Yoshida R, Nakajima M, Watanabe Y, Kwon JT, Yokoi T. Genetic polymorphisms in human CYP 2A6 gene causing impaired nicotine metabolism. British Journal of Clinical Pharmacology 2002; 54: 511–517
   PubMed Web of Science ®Google Scholar